Table 3.

Effect of Ang-(1−7) on NF-κB DNA-binding activity.

Groups studied	NF-κB activity
1. WKY	7.0 ± 0.5
2. SHR	25.0 ± 0.9*
3. SHR-Ang-(1−7)	3.6 ± 0.3*,†
4. Diabetic SHR	33.5 ± 1.3*,†
5. Diabetic SHR-Ang-(1−7)	3.5 ± 0.4*,†,§
6. Diabetic SHR-A779	38.7 ± 2.3*,†,§
7. Diabetic SHR-captopril	10.5 ± 0.6*,†,§
8. Diabetic SHR-captopril-A779	21.6 ± 0.8*,†,§,#

The data are expressed as mean ± SEM (N = 5).

^*Value significantly different from WKY, p < 0.05.

^†Value significantly different from SHR, p < 0.05.

^§Value significantly different from diabetic SHR, p < 0.05.

^#Value significantly different from diabetic SHR-captopril, p < 0.05.